Abstract
Objective: To describe and compare the clinical outcomes of bamlanivimab-etesevimab, casirivimabimdevimab, and sotrovimab treatment of mild to moderat......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
